• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从开菲尔中分离出的胞外多糖作为调节微生物群的潜在生物活性化合物。

Exopolysaccharides From Isolated From Kefir as Potential Bioactive Compounds for Microbiota Modulation.

作者信息

Bengoa Ana Agustina, Dardis Carolina, Gagliarini Nina, Garrote Graciela L, Abraham Analía G

机构信息

Facultad de Ciencias Exactas, Centro de Investigación y Desarrollo en Criotecnología de Alimentos, Universidad Nacional de La Plata - Consejo Nacional de Investigaciones Científicas y Técnicas Centro Científico-Tecnológico La Plata - Comisión de Investigaciones Científicas de la Provincia de Buenos Aires, La Plata, Argentina.

Área Bioquímica y Control de Alimentos - Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina.

出版信息

Front Microbiol. 2020 Oct 16;11:583254. doi: 10.3389/fmicb.2020.583254. eCollection 2020.

DOI:10.3389/fmicb.2020.583254
PMID:33178165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7596202/
Abstract

Microbiota coexists in true symbiosis with the host playing pivotal roles as a key element for well-being and health. Exopolysaccharides from lactic acid bacteria are an alternative as novel potential prebiotics that increase microbiota diversity. Considering this, the aim of the present work was to evaluate the capacity of the EPS produced by two strains isolated from kefir grains, to be metabolized by fecal microbiota producing short chain fatty acids. For this purpose, fecal samples from healthy children were inoculated in a basal medium with EPS and incubated in anaerobiosis at 37°C for 24, 48, and 72 h. DGGE profiles and the production of SCFA after fermentation were analyzed. Additionally, three selected samples were sequenced by mass sequencing analysis using Ion Torrent PGM. EPS produced by CIDCA 8339 (EPS) and CIDCA 83124 (EPS) are metabolized by fecal microbiota producing a significant increase in SCFA. EPS fermentation led to an increment of propionate and butyrate, while fermentation of EPS increased butyrate levels. Both EPS led to a profile of SCFA different from the ones obtained with inulin or glucose fermentation. DGGE profiles of 72 h fermentation demonstrated that both EPS showed a different band profile when compared to the controls; EPS profiles grouped in a cluster that have only 65% similarity with glucose or inulin profiles. Mass sequencing analysis demonstrated that the fermentation of EPS leads to an increase in the proportion of the genera , and and a significant drop in the proportion of enterobacteria. In the same direction, the fermentation of EPS also resulted in a marked reduction of Enterobacteriaceae with a significant increase in the genus . It was observed that the changes in fecal microbiota and SCFA profile exerted by both polymers are different probably due to differences in their structural characteristics. It can be concluded that EPS synthesized by both strains, could be potentially used as bioactive compound that modify the microbiota increasing the production of propionic and butyric acid, two metabolites highly associated with beneficial effects both at the gastrointestinal and extra-intestinal level.

摘要

微生物群与宿主以真正的共生关系共存,作为健康和福祉的关键要素发挥着关键作用。来自乳酸菌的胞外多糖作为一种新型潜在益生元,可增加微生物群的多样性。考虑到这一点,本研究的目的是评估从开菲尔粒中分离出的两株菌株产生的胞外多糖被粪便微生物群代谢产生短链脂肪酸的能力。为此,将健康儿童的粪便样本接种到含有胞外多糖的基础培养基中,在37℃厌氧条件下孵育24、48和72小时。分析发酵后的DGGE图谱和短链脂肪酸的产生情况。此外,使用Ion Torrent PGM通过大规模测序分析对三个选定的样本进行测序。CIDCA 8339(EPS)和CIDCA 83124(EPS)产生的胞外多糖被粪便微生物群代谢,导致短链脂肪酸显著增加。胞外多糖发酵导致丙酸和丁酸增加,而EPS发酵增加了丁酸水平。两种胞外多糖导致的短链脂肪酸谱与菊粉或葡萄糖发酵得到的不同。72小时发酵的DGGE图谱表明,与对照相比,两种胞外多糖均显示出不同的条带图谱;EPS图谱聚集在一个与葡萄糖或菊粉图谱仅有65%相似性的簇中。大规模测序分析表明,胞外多糖的发酵导致属、属和属的比例增加,肠杆菌的比例显著下降。同样,EPS的发酵也导致肠杆菌科显著减少,属显著增加。据观察,两种聚合物对粪便微生物群和短链脂肪酸谱的影响不同,这可能是由于它们结构特征的差异。可以得出结论,两株菌株合成的胞外多糖有可能用作生物活性化合物,改变微生物群,增加丙酸和丁酸的产生,这两种代谢物在胃肠道和肠外水平都与有益作用高度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8269/7596202/b003f3865de4/fmicb-11-583254-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8269/7596202/883dca50ff05/fmicb-11-583254-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8269/7596202/75c57bfbdf14/fmicb-11-583254-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8269/7596202/828c2e0cb9e1/fmicb-11-583254-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8269/7596202/b003f3865de4/fmicb-11-583254-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8269/7596202/883dca50ff05/fmicb-11-583254-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8269/7596202/75c57bfbdf14/fmicb-11-583254-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8269/7596202/828c2e0cb9e1/fmicb-11-583254-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8269/7596202/b003f3865de4/fmicb-11-583254-g004.jpg

相似文献

1
Exopolysaccharides From Isolated From Kefir as Potential Bioactive Compounds for Microbiota Modulation.从开菲尔中分离出的胞外多糖作为调节微生物群的潜在生物活性化合物。
Front Microbiol. 2020 Oct 16;11:583254. doi: 10.3389/fmicb.2020.583254. eCollection 2020.
2
Exopolysaccharide-producing strains isolated from kefir as starter for functional dairy products.从开菲尔中分离出的产胞外多糖菌株作为功能性乳制品的发酵剂。
Front Microbiol. 2023 Feb 24;14:1110177. doi: 10.3389/fmicb.2023.1110177. eCollection 2023.
3
Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.长双歧杆菌 IPLA E44 和动物双歧杆菌亚种。乳双歧杆菌 IPLA R1 产生的胞外多糖改变了 pH 控制批次培养中人体粪便微生物群的组成和代谢活性。
Int J Food Microbiol. 2009 Nov 15;135(3):260-7. doi: 10.1016/j.ijfoodmicro.2009.08.017. Epub 2009 Aug 19.
4
Effect of a novel animal milk oligosaccharide biosimilar on the gut microbial communities and metabolites of in vitro incubations using feline and canine fecal inocula.新型动物乳寡糖类似物对使用猫和犬粪便接种物进行体外孵育的肠道微生物群落和代谢物的影响。
J Anim Sci. 2020 Sep 1;98(9). doi: 10.1093/jas/skaa273.
5
Impact of growth temperature on exopolysaccharide production and probiotic properties of Lactobacillus paracasei strains isolated from kefir grains.生长温度对从开菲尔粒中分离的副干酪乳杆菌菌株的胞外多糖生产和益生菌特性的影响。
Food Microbiol. 2018 Feb;69:212-218. doi: 10.1016/j.fm.2017.08.012. Epub 2017 Aug 19.
6
In Vitro Effects of Dietary Inulin on Human Fecal Microbiota and Butyrate Production.膳食菊粉对人体粪便微生物群和丁酸盐产生的体外影响。
J Microbiol Biotechnol. 2015 Sep;25(9):1555-8. doi: 10.4014/jmb.1505.05078.
7
Lactobacillus paracasei ZFM54 alters the metabolomic profiles of yogurt and the co-fermented yogurt improves the gut microecology of human adults.副干酪乳杆菌 ZFM54 改变了酸奶的代谢组学特征,而共发酵酸奶改善了成年人的肠道微生物群。
J Dairy Sci. 2024 Aug;107(8):5280-5300. doi: 10.3168/jds.2023-24332. Epub 2024 Mar 8.
8
The impact of long-term dietary pattern of fecal donor on in vitro fecal fermentation properties of inulin.粪便供体的长期饮食模式对菊粉体外粪便发酵特性的影响。
Food Funct. 2016 Apr;7(4):1805-13. doi: 10.1039/c5fo00987a.
9
simulated digestion and fecal fermentation of exopolysaccharides from GL1.GL1 胞外多糖的模拟消化和粪便发酵
Food Funct. 2023 Jun 6;14(11):5120-5137. doi: 10.1039/d3fo00676j.
10
The effect of optimized carbon source on the synthesis and composition of exopolysaccharides produced by Lactobacillus paracasei.优化碳源对副干酪乳杆菌胞外多糖的合成和组成的影响。
J Dairy Sci. 2021 Apr;104(4):4023-4032. doi: 10.3168/jds.2020-19448. Epub 2021 Feb 5.

引用本文的文献

1
Potential of Kefir-Derived Peptides, Probiotics, and Exopolysaccharides for Osteoporosis Management.开菲尔衍生肽、益生菌和胞外多糖在骨质疏松症管理中的潜力
Curr Osteoporos Rep. 2025 Apr 7;23(1):18. doi: 10.1007/s11914-025-00910-9.
2
Optimization and semi-continuous fermentation of gluco-oligosaccharide production with YRK005.利用YRK005优化及半连续发酵生产低聚葡萄糖
Food Sci Biotechnol. 2024 Sep 9;34(4):991-1000. doi: 10.1007/s10068-024-01703-z. eCollection 2025 Mar.
3
Biological Activity of Lactic Acid Bacteria Exopolysaccharides and Their Applications in the Food and Pharmaceutical Industries.

本文引用的文献

1
Xylo-oligosaccharides from sugarcane show prebiotic potential in a dynamic computer-controlled model of the adult human large intestine.甘蔗来源的低聚木糖在成人大肠动态计算机控制模型中显示出益生元潜力。
Benef Microbes. 2020 Mar 27;11(2):191-200. doi: 10.3920/BM2019.0159. Epub 2020 Mar 25.
2
Prebiotics in the Infant Microbiome: The Past, Present, and Future.婴儿微生物群中的益生元:过去、现在与未来
Pediatr Gastroenterol Hepatol Nutr. 2020 Jan;23(1):1-14. doi: 10.5223/pghn.2020.23.1.1. Epub 2020 Jan 9.
3
Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health.
乳酸菌胞外多糖的生物活性及其在食品和制药工业中的应用
Foods. 2024 May 23;13(11):1621. doi: 10.3390/foods13111621.
4
Milk and BL23 effects on intestinal responses in a murine model of colitis.牛奶和 BL23 对结肠炎小鼠模型肠道反应的影响。
Am J Physiol Gastrointest Liver Physiol. 2024 Jun 1;326(6):G659-G675. doi: 10.1152/ajpgi.00259.2023. Epub 2024 Apr 9.
5
Unravelling the Gastroprotective Potential of Kefir: Exploring Antioxidant Effects in Preventing Gastric Ulcers.揭开开菲尔的胃保护潜力:探索抗氧化作用预防胃溃疡。
Cells. 2023 Dec 8;12(24):2799. doi: 10.3390/cells12242799.
6
Exopolysaccharide-producing strains isolated from kefir as starter for functional dairy products.从开菲尔中分离出的产胞外多糖菌株作为功能性乳制品的发酵剂。
Front Microbiol. 2023 Feb 24;14:1110177. doi: 10.3389/fmicb.2023.1110177. eCollection 2023.
7
Bacterial polysaccharides-A big source for prebiotics and therapeutics.细菌多糖——益生元和治疗药物的重要来源。
Front Nutr. 2022 Nov 3;9:1031935. doi: 10.3389/fnut.2022.1031935. eCollection 2022.
8
Characterization and Immunological Activity of Exopolysaccharide from GL1 Isolated from Tibetan Kefir Grains.从西藏开菲尔粒中分离出的GL1胞外多糖的表征及免疫活性
Foods. 2022 Oct 23;11(21):3330. doi: 10.3390/foods11213330.
9
Novel Insights for Metabiotics Production by Using Artisanal Probiotic Cultures.利用传统益生菌培养生产后生元的新见解。
Microorganisms. 2021 Oct 20;9(11):2184. doi: 10.3390/microorganisms9112184.
10
Bioactive Compounds from Kefir and Their Potential Benefits on Health: A Systematic Review and Meta-Analysis.从开菲尔中提取的生物活性化合物及其对健康的潜在益处:系统评价和荟萃分析。
Oxid Med Cell Longev. 2021 Oct 27;2021:9081738. doi: 10.1155/2021/9081738. eCollection 2021.
肠道微生物和代谢物作为血脑屏障完整性和大脑健康的调节剂。
Gut Microbes. 2020;11(2):135-157. doi: 10.1080/19490976.2019.1638722. Epub 2019 Aug 1.
4
"Physicochemical, immunomodulatory and safety aspects of milks fermented with Lactobacillus paracasei isolated from kefir"."从开菲尔中分离的副干酪乳杆菌发酵乳的理化特性、免疫调节及安全性方面"。
Food Res Int. 2019 Sep;123:48-55. doi: 10.1016/j.foodres.2019.04.041. Epub 2019 Apr 19.
5
Intestinal microbiome as a novel therapeutic target for local and systemic inflammation.肠道微生物组作为局部和全身炎症的新治疗靶点。
Pharmacol Ther. 2019 Jul;199:164-172. doi: 10.1016/j.pharmthera.2019.03.006. Epub 2019 Mar 12.
6
Shaping the Infant Microbiome With Non-digestible Carbohydrates.用不可消化碳水化合物塑造婴儿微生物群。
Front Microbiol. 2019 Feb 25;10:343. doi: 10.3389/fmicb.2019.00343. eCollection 2019.
7
The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases.使用益生菌疗法调节炎症性肠病中的肠道微生物群和树突状细胞反应。
Med Sci (Basel). 2019 Feb 22;7(2):33. doi: 10.3390/medsci7020033.
8
Probiotics, prebiotics and amelioration of diseases.益生菌、益生元和疾病改善。
J Biomed Sci. 2019 Jan 4;26(1):3. doi: 10.1186/s12929-018-0493-6.
9
High levels of butyrate and propionate in early life are associated with protection against atopy.生命早期丁酸和丙酸水平较高与预防特应性有关。
Allergy. 2019 Apr;74(4):799-809. doi: 10.1111/all.13660. Epub 2018 Nov 25.
10
The gut microbiome: Relationships with disease and opportunities for therapy.肠道微生物组:与疾病的关系及治疗机会。
J Exp Med. 2019 Jan 7;216(1):20-40. doi: 10.1084/jem.20180448. Epub 2018 Oct 15.